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Background: To determine the effects of Apis dorsata honey on the 
development of morphine tolerance and oxidative stress in rats.  
Materials and Methods: A total of 40 male Sprague Dawley rats were 
injected (subcutaneous) with 10 mg/kg of morphine following oral 
administration of A. dorsata honey (0.5, 1.5, and 2.5g/kg). On day 15, the rats 
were euthanized, and the thalamus, spinal cord, and hippocampus were 
homogenized to assess iNOS and MDA using ELISA kits.  
Results: The honey of A. dorsata significantly prevented morphine tolerance 
to analgesia in the hotplate test on Day 14 (p<0.05). The biochemical 
assessment showed that A. dorsata honey significantly reduced MDA 
formation in the brain regions compared to the morphine control group at 
dose 2.5g/kg. Elevation of iNOS caused by chronic morphine intake was 
reduced in A. dorsata honey co-treatment.  
Conclusion: This study suggests the therapeutic role of A. dorsata honey in 
preventing morphine tolerance via inhibition of oxidative stress. 
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Morphine is a commonly used opioid in acute and 
chronic pain management, such as regional anesthesia 
and joint pain (1). Although morphine possesses a 
protective effect against clinical injuries (2), prolonged 
exposure to chronic morphine treatment can lead to 
tolerance among patients. The tolerance has limited the 
patient to receive appropriate treatment, as they have 
to seek medical advice and monitoring for their 
increasing morphine doses. Thus, it is pivotal to search 
for a complementary agent to reduce morphine 
tolerance and to increase the sustainability of the 
morphine analgesic effect.  
The mechanism of morphine tolerance is related 
to the mu-opioid receptor (MOR) in the brain (3). 
Studies showed the role of oxidative stress in the 
development of morphine tolerance, as morphine itself 
can act as an oxidative stress-causing agent (4). 
Increased release of the free radical in response to 
tolerance led to the destruction of cell defense systems, 
indicating the elevation of oxidative stress (5-7). In 
addition, neuronal damages were associated with 
increased tolerance to the drug (8). 
Honey is a natural supersaturated solution of 
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sugar produced by honeybees. They are used 
traditionally to treat wounds, sore throats, and stomach 
ulcers (9, 10). Another study also significantly proves 
that honey acts as an antioxidant and neuroprotective 
agent (11). Evidence revealed that phenolic contents in 
honey have an anti-tolerance effect against morphine 
(12, 13). Malaysian A. dorsata honey has higher 
phenolic content and antioxidant capacity than other 
honey types such as gelam, Indian forest, and 
pineapple honey (14). Therefore, this study was 
conducted to evaluate the effect of Apis dorsata honey 
on morphine-induced tolerance using a hotplate test, as 





Animal: Animals were maintained in Animal 
Research Laboratory in Faculty of Medicine, 
Universiti Sultan Zainal Abidin (UniSZA). 40 Sprague 
Dawley male rats (200-250g each) were kept in a 
controlled temperature 22±2˚C and 12 hours light/dark 
cycle with free access to food and water ad libitum. The 
animals were habituated to the testing environment for 
at least two weeks before the experiment to adapt to the 
manipulation and minimize nonspecific stress 
responses. The Animal Experimentation Ethics 
Committee approved all experiments performed in this 
study of UniSZA (ID: UAPREC/16/003). 
 
Drugs and honey: Morphine (10mg/ml in 1 ml 
ampoule) was purchased from Hameln, Germany, and 
stored in 4˚C. Ketamin, xylazine, and zoletil were 
prepared into a cocktail based on the ratio described by 
Cheah et al. (15). A. dorsata honey was collected from 
A. dorsata beehives on Tualang tree (Koompassia 
excelsa) in Pasir Akar, Besut, Terengganu, Malaysia 
by the Department of Agropolis, Faculty of Biosource 
and Food Industry, UniSZA. 
 
Experimental group: Treatment group was 
established from the previous study design by Zakaria 
et al. (16) which consisted of five group (n=8) namely 
saline, morphine (10mg/kg) + saline, morphine 
(10mg/kg) + honey 0.5 g/kg, morphine (10mg/kg) + 
honey 1.5 g/kg and morphine (10mg/kg) + honey 2.5 
g/kg. These group are morphine (10mg/kg) + honey 0.5 
g/kg; morphine (10mg/kg) + honey 1.5 g/kg and 
morphine (10mg/kg) + honey 2.5 g/kg. Toxicity test on 
A. dorsata honey was carried out based on 
Organization for Economic Co-operation and 
Development (OECD) guideline for testing the 
chemicals (17).  
 
Induction of morphine tolerance: Morphine 
tolerance was induced by injection (subcutaneous) of 
morphine (10mg/kg) twice daily (9 am and 5 pm) for 
14 days (18). A preliminary study showed that this 
dose produces profound analgesia without causing side 
effects. Meanwhile, in the saline group, rats received 
1ml/kg saline via subcutaneous injection. To determine 
the effect of A. dorsata honey on the development of 
morphine tolerance, A. dorsata honey (0.5, 1.0, and 
2.5g/kg) was administered using oral gavage 30 
minutes before each injection of morphine. Control 
groups received saline (1ml/kg). 
 
Hotplate test: A hot plate test was carried out 30 
minutes after morphine administration. Each rat was 
placed in a Plexiglas box on a hotplate (Bioseb, France) 
with a temperature of 55˚C and surface area of 23 x 
23cm. Latency time for the rats to lick hind paws or 
jump (whichever came first) was recorded as post-drug 
latency (19). The cutoff time was set at the 30s to avoid 
tissue damage. Before drug administration, the hotplate 
latency was measured, and the average of the second 
and the third reading was taken as the baseline latency. 
Before the experiment, rats were tested for four days to 
obtain a stable hotplate response, and rats who failed 
to respond within 30 seconds were excluded from the 
experiment (20). The result was obtained based on the 
percentage of the maximum possible effect (%MPE) 
from the formula below (21): 
%MPE= 
Post drug latency−Baseline latency
Cutoff time−Baseline latency
 x 100 
A hotplate test was held on days 1 and 14 of the 
experiment in the morning. 
 
Sample preparation: On day 15, two hours after the 
last treatment in the morning, the rats were euthanized 
with ketamine, xylazine, and zoletil (KTX) cocktail 
and perfused via transcardial perfusion using 1X 
Phosphate Buffered Saline (PBS) pH 7.4. Thalamus, 
spinal cord, and hippocampus were dissected and 
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homogenized in 1X PBS pH 7.4 (1ml PBS/100mg 
tissue) using motor-driven TissueRuptor (Qiagen). 
Homogenized samples were centrifuged at 12000 rpm 
at 4̊ C using refrigerated micro-centrifuge. The 
supernatants collected were transferred into micro-
centrifuge tubes for immediate use or stored in -80̊ C 
for up to 6 months. Malondialdehyde (MDA) and 
iNOS concentrations in the samples were analyzed 
using an ELISA kit supplied by Cells Biolabs, Inc. 
(Catalog number: STA312), Elabscience, Inc. (Catalog 
number: E-EL-0060), and Cusabio, Inc. (Catalog 
number: CSB-E08325r). 
 
Data analysis: Statistical analysis was performed 
using Graph Pad Prism 6. Multiple comparisons in 
hotplate latency, MDA, and iNOS levels between 
groups were determined using One Way ANOVA 





Effect of A. dorsata Honey on the Development of 
Morphine Tolerance: Hot Plate Test: During the 
first day of the morphine tolerance development, the 
saline control group showed the lowest MPE% latency, 
suggesting no significant analgesic effect. Morphine-
induced groups showed a significant increase in 
analgesic MPE% compared to the saline group 
(p<0.05). The result indicated that the rats experienced 
analgesic effects induced by morphine. Co-
administration of A. dorsata honey at three different 
doses (0.5, 1.5, and 2.5 g/kg) did not inhibit or altered 
the analgesic latency as all these three treatment groups 
also showed significant MPE% compared to the saline 
group (Figure 1). Comparison between the three doses 
of A. dorsata honey with the morphine control group 
showed no significant differences of MPE% between 
them. This result suggested no significant effect of A. 
dorsata honey on morphine-induced analgesic effect 
on the first day of the treatment.  
On day 14, saline-treated rats experienced non-
significant analgesic effects MPE% compared to day 
one after 14 days of treatment, indicating no changes 
in analgesic effect. Meanwhile, the morphine alone 
group on day 14 demonstrated a significant reduction 
of MPE% compared to day one treatment, emphasizing 
the development of the tolerance that was developed 
following 14 days of morphine administration.  
As for A. dorsata honey-supplemented 
morphine groups, all three groups showed significantly 
higher MPE% of analgesic latency than morphine 
treatment alone (Figure 1). This result suggested that 
A. dorsata honey co-treatments have prevented the 
decrease of analgesic effect and the development of 
morphine tolerance. Among the three doses tested, the 
intermediate 1.5 g/kg A. dorsata honey has the highest 
prevention on the analgesic tolerance as the treatment 
gave the highest MPE% value on day 14. However, no 
significant differences in MPE% between 1.5 g/kg and 
2.5 g/kg honey dose. 
 
Effect of A. dorsata Honey on MDA Level in Brain 
Regions of Morphine-tolerant Rats: The result 
showed that repeated administration of morphine 
significantly increased the MDA level in the thalamus, 
spinal cord, and hippocampus compared to the saline 
group (p<0.0001) (Figure 2). Based on ANOVA 
multiple comparison analysis, co-administration of 
morphine with A. dorsata honey significantly 
decreased the MDA level in the thalamus and spinal 
cord at high dose (2.5 g/kg) (p<0.0001 respectively). 
Though not significant in other doses, A. dorsata honey 
reduced the MDA to a lower level than the morphine 
single group. Meanwhile, all three different doses 
significantly reduced the MDA formation (p<0.0001). 
Thus, the effect of A. dorsata honey in attenuating 
MDA formation in the brain was significant, 
particularly in the hippocampus. 
 
Effect of A. dorsata Honey on Inducible Nitric 
Oxide Synthase (iNOS) Production in Morphine-
Tolerant Rat Brain Region: Figure 3 shows that 
morphine injection for 14 days caused an increase of 
iNOS level in the thalamus, spinal cord, and 
hippocampus regions. Co-treatment with A. dorsata 




This current study investigated the effect of A. dorsata 
honey on morphine tolerance. The analgesic MPE% 
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value of morphine alone reduced to the level that has 
no significant difference compared to the saline group 
on day 14 of the morphine injection. This outcome 
showed that the tolerance to the analgesic effect had 
occurred and was completed on the 14th day of the 
morphine injection, as suggested by (18). 
Recent studies demonstrated the association of 
oxidative stress in the neurobiology of opioids (22, 23, 
4). Prolonged opioid receptor activation can cause 
excitotoxicity in the synapse (24). This condition is 
proposed to alter the analgesic cascades and down-
regulated the opioid system, causing an irreversible 
state of tolerance (25, 26). 
Based on the result obtained, A. dorsata honey 
possibly prevented the development of morphine 
tolerance via nourishment of antioxidants to neurons 
 
Figure 1. The effect of different doses of Apis dorsata honey on the development of morphine tolerance in rats on Day 1 
and day 14, respectively. Data represents MPE% mean±S.E.M. (n=8). *p<0.001 compared to the saline group. ** p<0.05 
compared to the morphine control group. # p<0.001 compared to the morphine control group. Graphs were obtained using 
GraphPad Prism 6. The supplement of A. dorsata honey prevents the development of tolerance compared to the morphine 
control group. Dose 1.5g/kg A. dorsata honey shows the highest prevention of tolerance (# p<0.001). 
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that decrease oxidative stress. The anti-tolerant effect 
of A. dorsata honey supplements is probably due to 
honey's antioxidant, analgesic effect, and anti-
inflammatory properties (27, 28).  
Honey is proven rich in phenolic acids and 
flavonoids that contributed to antioxidant activity such 
as gallic acid, benzoic acid, caffeic acid, catechin, 
luteolin, and apigenin (29). Several honey bioactive 
compounds were reported to have properties in 
reducing tolerance, such as ellagic acid and quercetin 
(12, 13). This finding highlighted the importance of the 
bioactive compounds on A. dorsata honey's anti-
tolerant properties. Inhibition of NO radical and RNS, 
an indicator of oxidative stress formation, can prevent 
the development of morphine tolerance (4, 30). Co-
treatment with honey was demonstrated to reduce 
 
Figure 2. Effect of A. dorsata honey supplement on the level of lipid peroxidation marker, MDA in morphine-tolerant 
rats’ thalamus, spinal cord, and hippocampus. One-way ANOVA followed by Tukey’s post hoc was used to analyze MDA 
differences between treatment groups. #p<0.0001 compared to the saline group. Co-administration of A. dorsata honey 
decreased the MDA formation, especially at 2.5 g/kg dose in the spinal cord and hippocampus (****p<0.0001 & 
***p<0.001 compared to the morphine control group, respectively). 
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tissue inflammation via inhibition of NO production 
(31).  
Our result showed that a high dose of A. dorsata 
honey (2.5 g/kg dose) caused a less protective effect on 
tolerance than intermediate-dose 1.5 g/kg, which gave 
higher inhibition, though statistically, it was not 
significant. Protective effect against tolerance is 
defined as the prevention of analgesic reduction after 
repeated exposure to morphine. Hence, in this study, 
we hypothesized that the differences between these 
two ranges of doses probably did not significantly 
affect tolerance development. Few factors contribute to 
tolerance development; doses and duration, 
interaction, metabolism (enzymes), polymorphism 
 
Figure 3. Effect of A. dorsata honey on iNOS level in morphine-tolerant rats’ thalamus, spinal cord, and hippocampus. 
One-way ANOVA followed by Tukey’s posthoc analysis was used to analyze the differences of iNOS between treatment 
groups. Data represents iNOS level mean±S.D. (n=8). Morphine control groups in all three regions demonstrated 
significant-high iNOS levels, **P<0.01 compared to the saline group. The co-administration of A. dorsata honey at 0.5 
g/kg significantly reduced the iNOS level, *P<0.05 compared to the morphine control group. H= A. dorsata honey. 
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(genetic) (32, 33). 
Our current results also indicated that the effect 
of A. dorsata honey on the MPE% was not dose-
dependent. One of the explanations for such possibility 
is the active interaction between compounds in A. 
dorsata honey. Another factor that may be involved is 
also the interaction of morphine with A. dorsata honey 
phenolic compounds. It is most probably contributed 
by interactions between more than one phenolic acid 
and flavonoid of the honey (34). This current result is 
in line with a previous claim, in which combination 
with phytochemicals can cause a polyvalent 
pharmacological action of the drug (35).  
In this study, the effect of A. dorsata honey gave 
a preliminary positive finding on its role as an 
antioxidant in reducing the tolerance of morphine. A 
possible explanation of this finding is mainly through 
antioxidant-free radical reaction in glutamate 
neurotoxicity upon morphine signaling. The result 
showed that a higher (2.5g/kg) dose gave less 
prevention of morphine tolerance. In the 
neuroprotective studies, the significant doses were 
varied, such as in a study by (36), 1.2 g/kg dose was 
significant in cerebral neuroprotective. Meanwhile, 
0.2g/kg and 1g/kg doses were significant for 
hippocampal and midbrain neuroprotective effects. As 
far as this study was conducted, there are not many 
reports on the optimal dose of A. dorsata honey. 
The variation of the bioactive contents in 
different honey contributes to the different rates of 
biological activities. Nature factors such as climate, 
floral source, and geographical area of honey sources 
may vary their chemical and bioactive composition and 
their biological activity levels (37). Briefly, it is 
considered challenging to determine the specific 
flavonoids or phenolic acids in every batch of honey 
and the efficacy of their antioxidant activities. Thus, it 
is recommended to analyze bioactive contents in each 
honey sample to determine active phytochemical 
content. 
Although co-administration of A. dorsata honey 
with morphine significantly prevented analgesic 
tolerance, the mechanism of A. dorsata honey in the 
morphine tolerance cannot be precisely determined 
because no A. dorsata honey control group was 
involved, which raises a question of whether the 
inhibition of tolerance is caused by the additive effect 
of the honey or the analgesic effect of the honey itself. 
Hence, the A. dorsata honey control treatment group 
should be beneficial to be included in future 
investigations. 
The outcome suggests that A. dorsata honey 
possibly prevented the increase in ROS/RNS and 
MDA. Concomitant treatment of honey significantly 
reduced the MDA formation, especially in the 
hippocampus, suggesting the protective effect of honey 
against free radicals. A. dorsata honey possibly 
prevents the development of morphine tolerance via an 
antioxidant defense mechanism attributed to its 
bioactive constituents. Previous reports on honey 
phytochemical contents also showed their protective 
effects against antioxidant deficits and lipid 
peroxidation in specific brain regions (38). 
At the molecular level, honey phenolic contents 
possibly participated in the morphine action site. The 
previous study has compared the activity of 
antioxidants in morphine action. Langsdorf & Chang 
(39) proved that antioxidants could reduce ROS and 
attenuates MOR expression. Based on our result in the 
hotplate test and MDA level, it can be suggested that 
the inhibition of the analgesic tolerance is possibly 
contributed by the A. dorsata honey antioxidant 
mechanism in opioid receptor signaling.  
Regarding the doses used, all of the three doses 
of A. dorsata honey significantly reduced MDA levels 
in the hippocampus of morphine-treated animals. In 
contrast, the MDA inhibition in the thalamus and 
spinal cord was only significant at the 2.5g/kg dose of 
A. dorsata honey. The mechanism governing the iNOS 
release under morphine tolerance can be related to glial 
activation by morphine. The previous investigation 
stated that the glial activation in morphine 
antinociception caused the release of iNOS (40). A. 
dorsata honey significantly reduced the iNOS level at 
the dose of 0.5 g/kg in the hippocampus (Figure 4). The 
result suggested that A. dorsata honey provides a 
neuroprotective effect against morphine tolerance to 
analgesic effect via reducing iNOS generation. One 
possible mechanism is that honey prevents the increase 
of NOO- and O2- in the glutamatergic pathway of 
morphine tolerance via antioxidant scavenging activity 
(41). 
The honey antioxidant may simultaneously 
participate with NO action in reducing opioid receptor 
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desensitization and eventually suppress morphine 
tolerance. The previous study has established the 
significance of antioxidants in attenuating NOS 
production and morphine tolerance compared to NOS 
inhibitor single treatment (42). 
Furthermore, it can be observed from the overall 
result that A. dorsata honey co-treatment reduced 
oxidative stress, specifically in the hippocampus, 
compared to other brain regions. Hippocampus is the 
site for modulation of behavioral response to 
nociceptive stimuli and opiate addiction (43). 
Compared to other regions, morphine treatment caused 
MOR-induced ROS generation, specifically in the 
hippocampus, altering the synapse (44). 
 Taken together, this study proposed the 
mechanism of A. dorsata honey in reducing tolerance 
to morphine analgesia, possibly via attenuation of 
morphine-induced oxidative stress in the morphine 
analgesic pathway. The treatment of A. dorsata honey 
was proven to reduce the formation of iNOS, with the 
possible reduction of NO radical release in the synaptic 
cleft. Subsequently, this condition reduces neuronal 
damage and protects the neuron from the alteration of 
morphine signaling. A. dorsata honey co-treatments 
potentially prevented the MDA and iNOS increase 




Administration of A. dorsata honey reduced the 
tolerance and oxidative stress biomarkers, 
demonstrated by the hotplate latency, MDA, and iNOS 
level. Thus, this study highlighted a new role of A. 
dorsata honey as a potent morphine tolerance-
preventing agent other than its well-known antioxidant 
activity. Apis dorsata honey might affect neuronal fate 
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